Feed and bedding Class JandA Jul-31-2014 DM



1. Contracting Activity:Department of Veterans Affairs (VA)Office of Acquisition OperationsStrategic Acquisition Center10300 Spotsylvania Avenue, Suite 400Fredericksburg, VA 224082. Description of Action: The proposed action is for medical supplies, under the authority of Federal Acquisition Regulation (FAR) 8.405-6, “Limited Sources.” The required items are supplied by Cardinal Health 200, LLC, large business, located at 3651 Birchwood Drive, Waukegan, IL 60085. These items will be procured via Federal Supply Schedule (FSS) V797P-4304B to populate the MSPV-NG formulary with mandatory health care supplies. The MSPV-NG formulary is a list of approved healthcare commodities including medical, surgical, dental, laboratory, facilities/cleaning products, and textiles. This LSJ will supply the MSPV-NG formulary with medical instrument and accessories distributed by Cardinal Health 200, LLC. on a not-to-exceed 12-month period of performance until these items can be competed in accordance with FAR 8.405-3. As the identified required items are competed, they will no longer be acquired under the LSJ; thus, bringing the MSPV-NG formulary in compliance with the FAR 8.405-3, “Blanket Purchase Agreements”.3. Acquisition History: VHA manages the largest integrated healthcare system in the United States. In 2013, the system consisted of 21 Veterans Integrated Services Networks with approximately 150 medical centers, 820 outpatient clinics, and various other facilities to include Community Living Centers, Veteran Centers and Domiciliaries. Together, these health care facilities, and the more than 53,000 independent licensed health care practitioners who work within them, provide comprehensive care to about 9.3 million enrolled Veterans. The MSPV Program is the primary means to obtain medical and surgical supply support for the VA healthcare system through contract support. VHA, in cooperation with VA’s National Acquisition Center (NAC), initiated contract support for the MSPV program in 2005. The result was the first generation of seven prime vendor distributor contracts that not only support VHA, but also support the Department of Health and Human Services, Department of State, Indian Health Service, and the Federal Bureau of Prisons.Since that time, VHA and NAC have successfully executed two long-term, multiple-award 5-year contracts in support of the MSPV program. In 2015, upon expiration of the second MSPV program, a set of bridge contracts were executed by the NAC extending the period of performance to April 19, 2016. Those bridge contracts were as follows: VA797N-15-C-0003, VA797N-15-C-0004, VA797N-15-C-0005, VA797N-15-C-0006, VA797N-15-C-0007, VA797N-15-C-0008, and VA797N-15-C-0009. In preparation for the continuation of the MSPV Program, the Strategic Acquisition Center (SAC) assumed responsibility to award the new MSPV-NG contracts in 2014. Due to a protest and continued technical evaluations, the SAC Contracting Officer determined that a second set of bridge contracts would be required to ensure continuity of services and the continuance of healthcare support throughout the VA community beyond the bridge contracts’ expiration on April 19, 2016. In February 2016, the SAC awarded the second set of bridge contracts. They are as follows: VA119-16-D-0007, VA119-16-D-0008, VA119-16-D-0009, VA119-16-D-0010, VA119-16-D-0011, VA119-16-D-0012, and VA119-16-D-0013. The period of performance for the second SAC bridge contracts began April 20, 2016, and will expire no later than April 19, 2017.Leveraging the NAC’s lessons learned, VHA and SAC developed a procurement strategy for a complete VA-wide MSPV formulary of approved supplies by April 2016. To execute this plan, VHA and SAC formed a team in February 2015, to initiate development of the MSPV-NG formulary. The goal of this team was to solicit and award approximately 7,000 individual line-items, identified as an optimal initial level, for the pending MSPV-NG formulary. The team developed a streamlined approach to solicit and award these items, which involved VHA providing salient characteristics for all 7,000 line-items, and SAC awarding competitive BPAs based on those salient characteristics. Between April 2015 and January 2016, VHA forwarded to SAC approximately 4,400 individual procurement packages consisting of both single and multiple line-items, of which approximately 3,500 were solicited and 900 returned to VHA for inclusion in future grouping efforts. Although SAC issued multiple Requests for Quotations (RFQs), vendor response rates averaged less than 30 percent. Due to lack of response, SAC and VHA sought input from industry via a series of MSPV-NG Industry Days. When queried, industry partners indicated two main problems: (1) VHA’s salient characteristics were flawed and/or insufficient. They did not appear to be based on clinical input, and often cited unnecessary manufacturer-specific features. This prohibited timely and quality responses, or no responses at all in many cases; (2) Industry also indicated the administrative burden of providing quotes for single-item BPA awards was not cost effective enough for them to provide quotes. In order to obtain a better success rate, and work on completing new MSPV-NG contracts, two possible strategies were identified: (1) VHA created supply-line commodity teams, and began seeking clinical input for the development of salient characteristics. Additionally, logical commodity groupings were developed; and (2) moving forward, VHA’s Program Management Office was to group line-items by supply-line categories, or by United Nations Standard Products and Services Codes. Supply-line categories were found to be the most favored by industry. In an effort to validate this, a Request for Information (RFI) was issued to industry in February 2016. The RFI results confirmed the supply-line category approach as the most appropriate method to solicit BPAs for item inclusion in the approved formulary. On February 24, 2016, awards were made to four MSPV-NG distributors, with an estimated performance starting 120 days after notice to proceed. The period of performance under these contracts are scheduled to begin on October 20, 2016. It was anticipated the distributors would have a full-line of 7,000 competitively awarded BPA formulary line-items to populate their electronic catalogs (e-catalog). Due to lack of vendor response, the formulary fell short of the necessary items required to complete the Prime Vendor’s e-catalog. In an attempt to resolve the shortfall identified above, numerous changes in VA’s strategy for populating the formulary were considered. This directly resulted in the need to establish additional MSPV bridge distribution contracts to ensure continuation of service. The MSPV bridge contracts were awarded with a start date of April 20, 2016. This included a 3-month base period of performance, and three 3-month option periods. The final period of performance expiration date is not-to-exceed 12 months. 4. Description of Supplies/Services: The MSPV-NG formulary will consist of two tiers: 1) the 1,600 line items previously competed by the SAC and NAC, which is being automatically populated into the MSPV-NG formulary and estimated to be ready for use by October 20, 2016; and 2) the additional FSS items identified by VHA to be procured under this LSJ. This group includes 388 types of medical and surgical supplies distributed by Cardinal Health 200, LLC. Examples of items covered under this category include various types of medical and surgical instruments and supplies. The full list of items covered under this LSJ is as follows: Part NumberItem DescriptionEstimated Quantity 20338-305ABOTTLE PERI FOR IRRIGATION3D1014PATIENT ISOLATION DRAPE2D1016POUCH LARGE FLUID55D2244ABSORBENT FEMORAL ANGIO22D2264DRAPE FISTULALATEX FREE162D2286ABSORBENT ANGIO SHEET3D1000RLDRAPE TOWEL SMALL20D1003BAG ISOLATION181D1010RLDRAPE TOWEL LARGE ON ROLL17D1017DRAPE PATIENT ISOLATION W/POUCH16D1018INSTRUMENT POUCH152D1030DRAPE LARGE APERATURE28D1060DRAPE INCISE OPHTHALMIC29D1067U-POUCH SHOULDER7D1071DRAPE UROLOGICAL4D1092DRAPE MINOR PROCEDURE61D2260DRAPE SUBCLAVIAN LATEX FREE13S1389-93SHIELD, FLEX, 9" X 12"21ISOQ-3000ISO-QUICK, SOLIDIFY 3000CC OF FLUID234SU130-5005POUR-SAFE EXUDATE DISPOSAL BAG10P5190-4FILTER SAMPLER 4IN X16MM 6283P5189-4FILTER SAMPLER 13MM X 4205P5192-1FILTER SAMPLER 16MM STANDARD4129725-010BRUSH SCRUB CUB ANCHOR143A9490-3S/P KEEPER SAFE BIO-CHECK BIOHAZARD246518-01LFBRA SURGI SMALL LATEX FREE846518-02LFBRA SURGI MEDIUM LATEX FREE2646518-04LFBRA SURGI XLARGE LATEX FREE9146518-03LFBRA SURGI LARGE LATEX FREE9046518-05LFBRA SURGI 2XL LATEX FREE SZ 42 EQUIV7746518-06LFBRA SURGI 3XL LATEX FREE SZ 44-46 EQUIV3130181-022BSHEET TISSUE DRAPE 40X48 2 PLY WHITE15430181-122BSHEET DRAPE 3-PLY 40 X 48 IN WHITE10145930-010BGOWN 3 PLY TISSUE WHITE274C8826-1CUP S/P SPECIMEN DISPO 8OZ13C8842-190ACONTAINER SP 190OZ WHITE WITH LID84C8842-16BCONTAINER WITH LID 16OZ15C8842-32BCONTAINER SP WITH LID 32OZ23C8842-86ACONTAINER WITH LID 86OZ FLEETWOOD110A9494-2WIPE BIOHAZ STANDARD ABSORB 4X4 S/P25A9495-1WIPE BIOHAZ SUPER ABSORBENT 3X3 S/P10A9495-3WIPE BIOHAZ SUPER ABSORBENT 8X9 S/P8A9494-3ROLL BIOHAZ STANDARD ABSORB 16INX100FT62A9494-1WIPE BIOHAZ STANDARD ABSORBENT 3X3 S/P11A9495-2WIPE BIOHAZ SUPER ABSORBENT 4X4 S/P17A9495-4ROLL BIOHAZ SUPER ABSORBENT 16INX100FT1AT7505-PMASK, SURGICAL76103BCOLD PACK, XSMALL, 5X5.5IN, BULK48AT54535MASK, SURGICAL DUCKBILL FOG FREE4107KWIK-KOLD COLD PK REG850AT71039MASK, SURGICAL HORIZONTAL TIES28AT71235MASK, SURGICAL FOG FREE FOAM87AT73035MASK, SURGICAL SOFT-TOUCH SENSITIVE WHT227AT74535MASK, SURGICAL FOG FREE FOAM131AT72835MASK, SURGICAL ANTI FOG ADHESIVE8512493-500STERILE 2 OZ. MEDICINE CUP1329430HIP DRAPE, TIBURON729560FEMORAL ANGIOGRAPHY DRAPE 8/CS713752-612DBLE BASIN SET W/DBLE WRAP KIT513752-610AM DOUBLE BASIN SET W/DOUBLE25AT752005MASK, SURGICAL ANTI FOG VAPOR8720104INSULATED COLD PACK, LARGE, 6X9IN37020204REUS COLD PK MED 6X6.511729130LAPAROTOMY PACK, TIBURON3129131UNIVERSAL SPLIT PACK, TIBURON7429136LAP PACK, TIBURON3529160SHOULDER PACK, TIBURON329013PACEMAKER DRAPE, 8/CS1529352TOP SHEET, TIBURON 14/CS5429365SHOULDER DRAPE PACK, TIBURON3729367SHOULDER DRAPE PACK, TIBURON4729137LAPAROTOMY PACK, TIBURON7529154CV SPLIT SHEET, TIBURON1529416BILATERAL LIMB SHEET, TIBURON4229417BILATERAL EXTREMITY DRAPE, TIBURON2529170PERI/GYN PACK TIBURON 12/CS1129420CHEST/BREAST SHEET, TIBURON3629171PERI/GYN PACK, TIBURON1229421TRANSVERSE LAP SHEET, TIBURON11929180ARTHROSCOPY PACK, TIBURON4429188EXTREMITY PACK TIBURON5629189EXTREMITY PACK TIBURON529431SPLIT SHEET, TIBURON729433DRAPE SPLIT SHEET TIBURON9429276TIBURON PERI-GYN PACK, 10/CS629450LITHOTOMY SHEET, TIBURON 10/CS1429458BRACHIAL ANGIOGRAPHY DRAPE, TIBURON9329459ANGIOGRAPHY DRAPE, TIBURON 16/CS1829460ANGIOGRAPHY DRAPE W/PANELS, TIBURON3129475LAVH DRAPE, TIBURON1229492PEDIATRIC DRAPE, TIBURON7829494NEONATAL DRAPE, TIBURON1729412EXTREMITY DRAPE W/ABC AND NON-SLIP PAD,8129413EXTREMITY DRAPE W/NON-SLIP PAD TIBURON4129414EXTREMITY DRAPE TIBURON1929522THYROID SHEET, TIBURON4429422THYROID SHEET TIBURON21129425PFANNESTIEL SHEET, TIBURON2929456ANGIOGRAPHY DRAPE, TIBURON329490PEDIATRIC PACK, TIBURON1829919UPPER EXTREMITY DRAPE, TIBURON729496DRAPE MINOR PROCEDURE2229556ANGIOGRAPHY DRAPE XL, TIBURON130635-611PORTA SAMPLE COLD PK 3X8.254351BCONNECTOR SIMS13523POLYLINED ABS, FENESTRATED TOWEL72352ACONNECTOR T N/S10353ACONNECTOR STERILEAIGHT 1/4173358ACONNECTOR Y TYPE 1/431360ACONNECTOR 6 IN 1 STERILE5368PH CONNECTOR STER "Y" 1/4"2369PH CONNECTOR STER "Y" 3/8"7259405DRAPE, EXTREMITY, HEAVY DUTY6159413DRAPE, ARTHROSCOPY WITH POUCH1059438SPLIT SHEET, HEAVY DUTY ORTHOPEDIC8665651-530LINER CANNSTR SUCT 3000CC DISP8365652-0088 INCH DIP TUBE FOR SAF-T PUMP3065652-01616 INCH DIP TUBE FOR SAF-T PUMP265652-122CONVERTOR SPECIMEN PLASTIC2265652-123SPECIMEN CONVERTER ARTHOSCOPY9265652-124SPEC. CONVERTOR,PLAS,1/2" I.D.1465652-131UNIV TUBING BARB7365652-139BRACKET RING W/ON-OFF VALVE6865652-143BRACKET RING F/1200CC CAN12965652-145WALL PLATE W/HOLES3665652-155BRACKET RING 1200CC W/STRAIGHT35765652-518CANISTER CRD 1500CC W/STRAIGHT2865652-586MOBILE SUCTION CART,1000CC965652-596REGULATOR MOBILE SUCTION CART465652-6313000CC FLEX CANISTER1065652-904UNIV FLEX OUTER CANISTER HOLDR7965652-905UNIV FLEX OUTER CANISTER HOLDR10065651-4303000CC PPV GUARDIAN CANISTER1865651-930CLINER 3000CC FLEX ADVANTAGE9765652-004MANIFOLD 4 CANISTER NO ON/OFF765652-135BRKT RING 2000/3000CC W/STRGHT1565652-148RING FOR 1200CC24965652-159BRACKET GUARDIAN RING 1200 W/3965652-516CANNISTER SUCTION 1500CC W/VAL4265652-542ATUBES TANDEM 18''31865652-562CRD CAN W/ D.I.S.S., DIRECT TO REG CONN62865652-616CANNISTER SUCTION 1500CC FLEX26570304REUSABLE GEL PACK, M, 4.5X10.5IN2817445DRAPE OPHTHALMOLOGY, ASTOUND10380104INSULATED REUSABLE GEL PACK,L,6X9IN268386BACK TABLE COVER, 65X90IN, HEAVY-DUTY, S18420DRAPE LEGGINGS 2/PK1048421LEGGING 48 X 31368430LEGGINGS, IN-VIEW, CLEAR POLY578475PLASTIC U DRAPE, 60X84808484DRAPE UNDER BUTTOCKS W/POUCH138486UBD DRAPE WITH FLUID CONTROL POUCH 20/CS198482DRAPE UNDER BUTTOCKS W/FLUID598483DRAPE UNDER BUTTOCKS LAMINATED479011ELSMARTSLEEVE, LARGE/X-LONG3159041ELSMARTSLEEVE, X-LARGE/X-LONG29070GOWN XX-LRG POLY-REINFORCED519071ELSMARTSLEEVE, XX-LARGE/X-LONG619101PACK BASIC839120GENERAL ENDOSCOPY PACK TIBURON259158CV SPLIT SHEET, TIBURON 8/CS19154CV GROIN DRAPE, TIBURON109155CARDIOVASCULAR SPLIT DRAPE, TIBURON219195HEAD & NECK PACK, TIBURON539385OVERHEAD TABLE COVER, TIBURON 12/CS599414EXTREMITY DRAPE, TIBURON149428LAP CHOLE DRAPE, TIBURON1199413ARTHROSCOPY SHEET, TIBURON139446LARGE DRAPE SHEET, ASTOUND789449NEURO DRAPE W/ XL POUCH109447EENT SPLIT DRAPE, 8/CS99461DRAPE SHEET, ASTOUND339556HEAD/BAR DRAPE, ASTOUND2ASU1510RINSUFF,10' 0.1MICR ROTATE LUER13ASU1540INSUFF, 10', PLAIN END, 0.1 MI23C18700-020PIN SAFETY MED STERILE 2EA/PK 100PK/CS28CT-131CARDIOTHORACIC MULTIPORT CONNECTOR1H1SHIELD50SECUREGARD VISOR, ONE-PIECE, HALF-SHIELD2JP-2186JP CHANNEL DRAIN 10FR, FULL FLUTES1JP-2189JP CHAN DRN SIL RND 15FR FULL W/TRO1JP-2190JP CHANNEL DRAIN 19FR, FULL FLUTES1JP-2191JP CHAN DRN SIL RND 19FR FULL W/TRO4JP-2213JP CHANNEL DRAIN 10MM, 3/4 FLUTES21JP-2234JP CHANNEL DRAIN, 24FR HUBLESS26JP-HUR190HEMADUCT, 19FR 3/4 DUCTED2JP-2211JP CHANNEL DRAIN 7MM, FULL FLUTES2JP-2214JP CHANNEL DRAIN 10MM, FULL FLUTES13JP-2229JP CHAN DRN SIL HUBLESS 15FR W/TRO46JP-2230JP CHANNEL DRAIN, 19FR HUBLESS45JP-2231JP CHAN DRN SIL HUBLESS 19FR W/TRO19K718FR FRAZIER SUCTION HANDLE5K7210FR FRAZIER SUCTION HANDLE3K7312FR FRAZIER SUCTION HANDLE11K770POOLE SUCTION HANDLE13N1010SUCTION TUBING, 10 FOOT6SU130-0325DRAIN JACKSON-PRT 19FR W/TROC24SU130-0521DRAIN JACKSON-PRT 10FR W/TROC8SU130-1323DRAIN JACKSON PRATT ROUND 15FR104SU130-1325JP 19FR SILICONE DRAIN39SU130-0321DRAIN JACKSON PRATT 10FR 7MM53SU130-1308DRAIN JACKSONPRATT FL7MM3/4 PE48SU130-1309DRAIN JACKSON PRATT 10MM 3/4PR108SU130-1320DRAIN JACKSON PRATT RND7FR END13SU130-1348DRAIN/RESERVOIR JACKSON PRATT11SU130-1349DRAIN JACKSONPRATT FL10MM3/4PF64SU130-1360KIT DRAIN 100CC W/7MM PERF30T4031-50AGRINDER TISSUE CONICAL 50ML122T4031-35AGRINDER TISSUE FREE STANDING 35ML118S1046FILAMENT REINFORCED SKIN CLOSURES 1/4X434S1047STRIP WOUND CLOSURE 0.5IN X 4IN15S1040STRIP WOUND CLOSURE 0.125IN X 3IN8212PRMARKER SKIN MULTI TIP 6'' RU148212WPRAMARKER SKIN REG TIP 6'IN RULER STERILE115250GPRMARKER SKIN REG TIP 6'' RULE328PP-100NON-STERILE SKIN MARKING PEN96250GPRLMARKER SKIN REG TIP RUL & LA497250PRMARKER SKIN MULTI TIP 6'' RU2548-2RGLIGHT HANDLE, RIGID, GREEN, 2EA/PK411272335CHART PAPER, MARQUETTE 9402-0247332475120CHART PAPER MARQUETTE 9402-020, Z-FOLD224576123PAPER PRINTER CHART ROLLED MDCL 40477A/B1213549724CHART PAPER HP M1707A, Z-FOLD2793671264CHART PAPER SPACELABS 307438, ROLLED39WC102HOLDER FOR WC101A/WC108014677-493ULTRA FOREHEAD TEMPERATURE IND2930085-021BPILLOWCASE TISSUE/POLY WHITE 100/CS686B43505LAMP 3.5V HALOGEN30B43508LAMP 3.5V HALOGEN629470CYSTOSCOPY PACK, TIBURON, 10/CS89225UTFLMARKER UTILITY WITH LABELS FINE TIP38CF-1001SOLUTION ANTI FOG W/ FOAM PAD369UT-50MARKER UTILITY WITH LABEL REG TP NONSTER1329559LINE INSERTION DRAPING SYSTEM, 10/CS830085-020BSHEET STRETCHER TISSUE/POLY 40 X 90 IN1347SSK9004ASTERILE PITCHER 07051B1077-24SP BRAND RAPID TEST HCG CONTROLS67SSK9005ASTERILE EMESIS BASIN 07030JP-2227JP CHAN DRN SIL HUBLESS 10FR W/TRO20JP-2210JP CHANNEL DRAIN 7MM, 3/4 FLUTES7JP-2215JP CHANNEL DRAIN 10MM, FULL FLUTES W/TRO3JP-2226JP CHANNEL DRAIN 10FR HUBLESS14JP-2228JP CHANNEL DRAIN 15FR HUBLESS10SPP99DT1AADUAL TIP MARKER SURGICAL MARKER 41SPP99DT2AADUAL TIP MARKER WITH LABELS 0702289005SMARTGOWN, SMALL, 20/CS19795995ASTOUND STD GOWN, XXXL/XLONG 20/CS105C1560-004BLADE TONGUE JR STERILE AHC142C1565-006BLADE TONGUE 6IN STANDARD48C15052-008RAYON-TIP APPLICATOR W/PAPER SHAFT 8"37013819-116BOWL UTILITY NON-STERILE 16OZ TYVEK513819-132BOWL UTILITY 32OZ NONSTERILE2123640-120STOCKING KNEE LENGTH SMALL REGULAR4823640-125STOCKING KNEE LENGTH SMALL LONG2423640-140STOCKING KNEE LENGTH MED REGULAR38423640-160STOCKING KNEE LENGTH LARGE REGULAR6023640-180STOCKNG KNEE LENGTH X-LRG REGULAR10923640-185STOCKING KNEE LENGTH X-LRG LONG14423640-320STOCKING THIGH LENGTH SMALL REGULAR4723640-325STOCKING THIGH LENGTH SMALL LONG1923640-365STOCKING THIGH LENGTH LARGE LONG3623640-520STOCKING ANTI-EMB KNEE-LENGTH SM/REG1123640-540STOCKING ANTI-EMB KNEE-LENGTH MED/REG4723640-560STOCKING ANTI-EMB KNEE-LENGTH LG/REG32523640-580STOCKING ANTI-EMB KNEE-LENGTH XL/REG1123640-660STOCKING ANTI-EMB THIGH-LENGTH LG/REG1123640-680STOCKING ANTI-EMB THIGH-LENGTH XL/REG701D2863-22SURG-BLADE SZ 22 STAINLES STEL39TUMBLERGRYTUMBLER GRAY17WBASINMAVWASH BASIN RECTANGLE 6QT MAUVE61ED2015-NODEVICE EDGE SAFETY 20GX11/2IN203AT74635-IMASK, SURGICAL FOGFREE ANTI GLARE41ASC1200PULSEWAVE TV,CASS,SNGL 33CM20ASC1201VALVE PULSEWAVE TRUMPET9ASC1210PULSEWAVE TV,CASS,SNGL 28CM2ASU1201PROBE 5MM X 33CM, DISP FIXED15ASU1510INSUFF,10' 0.1MICRON STD LUERS107K60FLEXI-CLEAR, FINE CAPACITY2K61HANDLE FLEXICLEAR REG CAPACITY84K62FLEXI-CLEAR, HIGH CAPACITY8K87VCLEAR YANKAUER,OPEN TIP,VENTED98N6100TUBING NON-CON 1/4X100' BULK850D5510BAG, ISOLATION, 18 X 18, ST251ED12558-TBNEEDLE PRO 1ML 25GX5/8 TUBERCULIN196ED12905-INNEEDLE PRO 1ML 29GX1/2 U 100 INSULIN147ED2515-NODEVICE EDGE SAFETY 25GX11/2IN197ED27125-NODEVICE EDGE SAFETY 27GX11/4IN2T40311AINDICATOR TAPE STEAM 1 IN1T40313AINDICATOR TAPE BLUE STEAM 1 IN14C2289SPECIAL PROCEDURE DRAPE2246518-07LFBRA SURGI 4XL LATEX FREE229521TIBURON FEMORAL ANGIO DRAPE WITH POUCHES12ED12705-TBNEEDLE PRO 1ML 27GX1/2 TUBERCULIN17965410-010CAUTERY LOW TEMP FINE TIP 10/BX6465410-025CAUTERY LOW TEMP ELONGATED FINE 10/BX1865410-191CAUTERY HIGH TEMP ADJUST FINE TIP 10/BX4265410-180CAUTERY HIGH TEMP MICRO FINE TIP 10/BX15165410-290CAUTERY LOW TEMP FINE TIP 10/BX289438TIBURON LAPAROSCOPIC ABDOMINAL DRAPE27300-2SSCLEANER CAUTERY TIP STERILE530503-012ACUFF SOFT SM AD 2 TUBE SCREW530503-013ACUFF SOFT ADULT 2 TUBE SCREW330503-014ACUFF SOFT LG AD 2 TUBE SCREW530503-11ACUFF CARDINAL SOFT CHILD730503-15ACUFF SOFT THIGH CARDINAL2230503013SACUFF SOFT ADULT 1 TUBE SCREW830503312SACUFF SOFT SMALL ADULT 1 TUBE BAYONET8730503314LACUFF SOFT LG ADULT LONG 1 TUBE BAYONET4830503315SACUFF SOFT THIGH 1 TUBE BAYONET230503612ACUFF SOFT SMALL ADULT 2 TUBE LOCKING4130506-13ACUFF VINYL ADULT CARDINAL7730506-14ACUFF VINYL LARGE ADULT CARDINAL430506-14LACUFF VINYL LARGE ADULT LONG CARDINAL530506-15ACUFF VINYL THIGH CARDINAL530506312SACUFF VINYL SMALL ADULT 1UBE BAYONET758339PLASTIC MAYO STAND COVER 22/CS731585STOCKINETTE,IMPERVIOUS,MEDIUM181586STOCKINETTE,IMPERVIOUS,LARGE218376COVER TABLE 44X751668380COVER TABLE 80X902668441EYE DRAPE, ASTOUND68474U-DRAPE POLY W/6X21''SPL 60X60808750PAD PREP 24X44 W/9 CUFF929071SMARTSLEEVE, XX-LARGE989112BASIC PACK, TIBURON1569444DRAPE SHEET ASTOUND XL1129462DRAPE SHEET W/FENESTRATION, ASTOUND2039505GOWN STERILE BACK W/TOWEL S/M2619562OPHTHALMIC DRAPE, ASTOUND3729445TIBURON 4X40 SPLIT SHEET DRAPE 8/CS3359439TIBURON HD HIP DRAPE W/POUCHES 4 EA/CS49ECH-01HANDLE LIGHT RIGID DISP ECOCHOICE 1-UP113T40317LFINTEGRATOR EO241MPLG02MESH PANT STRETCH L XX-XX" 2EA7MPXLG02MESH PANT STRETCH XL XX-XX" 2EA13KPXLG02PREMIUM STRETCHABLE KNIT PANT XL 45-7014MPLGMESH PANT STRETCH L XX-XX" 5EA1BBAR01BRIEF BARI 3XL UP TO 95IN WAIST WHITE406UWHLG85UWEAR HEAVY LARGE 44-58IN WAIST19AT752007MASK, SURGICAL ANTI FOG VAPOR XL30BVHXL230BRIEF X-LARGE 58-64" HEAVY ABSORBENCY219BPHS200BRIEF PREMIUM BREATHABLE SMALL 22-36"7BEUXL820BRIEF MAXIMUM XL 59-64IN WAIST BEIGE84BVHMD210BRIEF MED 32-44" HEAVY ABSORBENCY172UWMXL25UNDERWEAR XL 58-68" MOD ABSORBENCY6MPXLGMESH PANTS XL STRETCH TO 62IN WAIST8BPH2XL630BRIEF PREM HVY 2XL 63-69IN WAIST GREEN477BPHM600BRIEF PREMIUM BREATHABLE MED 32-44"7UWHMD80UWEAR HEAVY MEDIUM 32-44IN WAIST11LT2336UPSSTD UNDERPAD 36X23IN, LIGHT50HVY2336UPSSTD UNDERPAD 36X23IN, HEAVY23MP2XLGMESH PANTS 2XL STRETCH TO 74IN WAIST2UWHXL90UWEAR HEAVY XL 58-68IN WAIST20HVY3036UPBBREATHABLE UNDERPAD 36X30IN, HEAVY90ERT100LCELECTRODE, ECG, RESTING TAB, 100 PACK1061UWM2XL30UNDERWEAR 2XL 68-80" MOD ABSORBENCY48EBASINGRY1EMESIS BASIN 500ML/16 OZ GRAY21EBASINMAV1EMESIS BASIN 500ML/16 OZ MAUVE3TD-29TRANS FILM DRESSING 8X12IN STER23CSC-CRMBR4CREAM BARRIER PROTECTANT ZINC 4OZ22FP-WHLCHRWHEELCHAIR PAD CONVOLUTED FOAM1310.21.EM2.0MM DRL BT/QC/125MM3310.31.EM3.2MM DRILL BIT/QC/145MM8310.221.EM2.0MM CANNULATED DRILL BIT/QC 150MM2292.68.EM2.8MM THREADD GUD WR TRO PT 300MM7310.26.EM2.7MM DRL BT/QC/100MM1292.622.EM1.1MM THREADED GUIDE WIRE 150MM2207.640.EM4.0MM CANLTD SCRW SHORT THREAD/40MM2207.632.EM4.0MM CANLTD SCRW SHORT THREAD/32MM1FBEDPANMAVBEDPAN FRACTURE MAUVE29CBEDPANGRYCONVENTIONAL BEDPAN GRAY7MEASUREOPQMEASURE TRIANGLE 32OZ OPAQUE/FLEXIBLE160CBEDPANMAVCONVENTIONAL BEDPAN MAUVE2WBASINGRYWASH BASIN RECTANGLE 6QT GRAY19CARAFEMAVWATER PITCHER MAUVE298WCACGM108CADULT CIRCUIT, 120IN EXPANDABLE TBG2CHAXX6005AADULT CIRCUIT,60IN CORRUGATED TBG1CHAXX9050BADULT CIRCUIT,90IN EXPANDABLE TBG37CHAXX7250BADULT CIRCUIT,72IN COAXIAL TBG27FP-HEAD7HEAD DONUT 7IN FOAM POSITIONER22FP-LARMCFOAM LAMINECTOMY ARM CRADLE255FP-HEAD9HEAD DONUT 9IN FOAM POSITIONER250AMMAD5CHTRADITIONAL MASK, MED ADULT SZ 52FP-BAW2FOAM BODY ALIGNMENT WEDGE, 18"L3URINALFURINAL FEMALE125DCUPMAVDENTURE CUP 8OZ MAUVE196WC8OZWOUND CLEANSER 8OZ1RGFB45AGREINFORCED GELLING FIBER +AG 4X4.75IN1SPECPAN01SPECIMEN PAN145The reprieve offered by this LSJ will allow VHA to continue placing orders under the MSPV-NG contracts on a temporary basis, and avoid an interruption in the healthcare supply chain while SAC pursues competitive procurements for the MSPV-NG formulary items. The proposed types of medical supplies will be ordered under the authority of this LSJ. These items have been identified as high-use medical items vital to the successful implementation of the MSPV-NG program. VHA analyzed the fiscal year (FY) 2015 Medical Products Data Bank, focusing on the top high-volume purchases and identified 4 types of critical medical supply distributed by Cardinal Health 200, LLC. Until the MSPV-NG formulary is completed, VHA’s ordering officers will be allowed to place orders for the required medical supplies. The anticipated total value of the proposed BPA over the life of the agreement is $1,205,817.59. The period of performance is not to exceed 12 months. 5. Statutory Authority and Supporting Rationale: The statutory authority permitting other than full and open competition is in accordance with FAR 8.405-6(a)(1)(i)(A), an urgent and compelling need exists, and following the procedures would result in unacceptable delays. 6. Rationale Supporting the Authority Cited Above: Urgent and compelling circumstances which significantly affect the interest of the Government will not permit competition in accordance with FAR 8.405-3, “Blanket Purchase Agreements (BPAs)”. Significant adverse consequences will occur if the LSJ is not approved as the VA health care supply chain will be negatively impacted. Continuance of the MSPV Distribution Program is vital; any delay of distribution will directly impair the delivery of healthcare and services to approximately 9.5 million Veterans currently receiving care through the VA Healthcare System. A break in the health care supply chain will hinder or halt the delivery of essential medical, surgical, dental, and laboratory supplies and other contracted medical/surgical, cleaning, rescue and safety supplies and services used in the direct delivery of patient care. The VA Healthcare System receives approximately 40% of its medical and surgical supply support through the national MSPV Program. Many of these items are standardized throughout the VA Healthcare System, and are a part of the formulary being developed for use in the VA. The formulary drives efficiency and familiarity in clinical practice which leads to improved patient outcomes and safety. It also decreases variation, thus reducing time to train and results in fewer errors when providing care. Standardization provides healthcare system benefits that are maximized because standardized items are interoperable. Facilities can then reinvest the savings earned into equipment and personnel that further enhance patient care.Estimated cost reduction for purchase of individual items through the MSPV formulary is approximately $4M over the course of the twelve months proposed under this LSJ. The $4M estimate does not account for efficiencies in the ordering and inventory management processes. Overall annual inventory reduction specifically attributable to MSPV is estimated at approximately $40M. Disapproval of the LSJ will result in a disruption in the health care supply chain and negate these potential savings as facilities source supplies through other means. Workload, man-hours, and cost of operations will increase as already depleting resources are lost and the agency will revert to the inefficient means of sourcing medical supplies as before the introduction of the national MSPV program in 2005. Those inefficient methods include use of purchase cards and local VHA contracting. Use of purchase cards as an ordering method has shown to be more than 5 times the workload burden of using the delivery order method under the MSPV program. In addition, there are approximately 2000 contracting staff in VHA, processing 576,134 formal contracting actions annually. If the MSPV Ordering Officers were unable to place orders via MSPV, and those transactions were added to the workload of an already overburdened contracting staff, the result would be catastrophic. Lead times to procure these items through contracting for other than emergency orders are 45 days; emergency orders require action within three days. All orders would become emergencies to ensure timely delivery of healthcare to Veterans. Canceled surgeries due to lengthy supply lead times would possibly become the norm, and thus, adversely affecting timely access to care. Items critical to provide immediate care will be jeopardized, and will directly impact the safety and lives of Veterans. VA has a critical role in the comprehensive emergency response to support local, regional, or national emergencies or disasters. VA is charged with the delivery and coordination of support missions for VA facilities affected by disasters,?and also performs missions assigned to VA by FEMA or?US Dept. of Health & Human Services?for response to and recovery?from nationally-declared emergencies and disasters.? The Prime Vendor Program is critical to ensure VA provides a full range of support to healthcare facilities to ensure resiliency, continuity and rapid recovery of healthcare services during disasters and other potential?disruptions to healthcare service delivery. VAMCs and other select Federal facilities are designated Federal Emergency Medical Facilities with significant contingency and emergency response roles. Accordingly, the MSPVs provide emergency supply support during major catastrophic events. Any interruption in the health care supply chain significantly jeopardizes the ability of VA to ensure minimum disruption to delivery of critical services in a contingency situation. This would directly impact healthcare delivery to our nation’s Veterans.Other alternatives were considered, including using both the legacy bridge contracts, and the MSPV-NG contract concurrently until all of the required items can be competitively awarded. The confusion this would create in the field is insurmountable, as field staff will face the uncertainty of which contracts to use and when. A well coordinated supply chain is necessary to ensure facilities are supported, and Veterans are cared for timely. There are no reasonable alternatives that would adequately address the circumstances presented. Any financial costs incurred by the Government to execute the BPAs under the authority of the LSJ, and any potential costs or cost avoidance not realized through competition would not outweigh the benefits received through continuance of the health care supply chain. Approval of the LSJ is in the best interests of the Government and is justified by the urgency of the circumstances. The cost to the Government if the LSJ is not approved would not be primarily financial, although it is significant. The non-monetary costs of the health, welfare and safety of millions of Veterans cannot be quantified. Every effort was made to compare these costs, benefits and other options; the VA cannot rationally find any other reasonable or timely alternative.VA considered the cost to the integrity of the procurement system and VA acknowledges the importance of protecting the integrity of the procurement system. However, VA feels this is an extraordinary situation, and maintains that due to an already constricted schedule, and the significant impact of these BPAs on the delivery of medical and surgical supplies and services to millions of Veterans, the facts of this case justify the unusual measure proposed under this LSJ. VA considered the balance of the integrity of the procurement system, and the interest of the Government and determined that the issuance of the BPAs under the authority of this LSJ is mitigated and justified. A break in the health care supply chain will be costly and detrimentally disruptive to VA operations and delivery of critical healthcare services to 9.5 million Veterans. Items procured under the authority of this LSJ will be included in the MSPV supply chain for a maximum period of twelve months until the item can be competitively awarded. At such time the item will be removed from the supply chain and replaced with the competitively awarded functional equivalent.This action is vital to support VA’s nationwide healthcare system and prevent disruptions to Veteran care. The identified medical items represent supplies collectively determined essential by VHA medical centers to meet VA patient care needs. Continued use of these products and source of supply will ensure timely delivery and minimize VA supply chain interruptions. The vendor for these items was selected through use of data analytics tools and the Medical Product Data Bank (MedPDB). The MSPV-NG program is the primary means to obtain medical supplies; these items are regarded as critical to patient care. These items are currently available under the legacy MSPV contracts. Failure to make them available under MSPV-NG would have catastrophic effects on the field’s ability to support medical centers. Each item would have to be purchased individually either via purchase card, or through local VHA Contracting Offices, with lead times of up to 45 days. VHA Logistics and Contracting do not have the capacity to meet the constant throughput of high cost/high volume daily individual orders required to meet clinical care needs. Bottlenecks resulting from capacity issues would result in insufficient inventory to meet critical needs for Veteran patients, and will have a significant patient safety impact. It is imperative that VA transition from the present way of doing business under the current MSPV program to the new and revised mandatory MSPV-NG program. In executing this change the following improvements will be realized:The MSPV-NG distributors shall not ship any medical/surgical or any other supplies that are not on the Government-provided MSPV-NG formulary of approved medical/surgical supplies.The MSPV-NG distributors shall not charge any VA formulary approved suppliers to handle their product in conjunction with the contract.The Government mandates all distributors to be Electronic Data Interchange compliant and it is in the BPAs/contracts. The MSPV-NG distributors shall not require product suppliers to carry liability insurance in excess of $1,000,000, charge tracking fees, and/or require additional discounts from product suppliers. 7. Efforts to Obtain Competition: MSPV-NG distribution contracts were awarded on February 24, 2016, and performance is scheduled to begin on October 20, 2016. The MSPV-NG distributors require VA’s formulary in order to fulfill the medical requirements at VA hospitals and clinics. As stated previously, the Government intends to compete all line items within the next 12 months. Market research shows there is adequate competition in support of the new requirements. In accordance with FAR 5.301 and 8.405-6(a)(2), these actions will be synopsized on Federal Business Opportunities Page (FBO). 8. Determination of Best Value: In accordance with FAR Subpart 8.404(d), the prices for supplies offered on FSS have already been determined to be fair and reasonable by NAC Contracting Officers. Given VHA’s critical need for the previously identified formulary supplies, and the short turn-around time until the MSPV-NG formulary is fully implemented, VA intends to select the lowest published FSS vendor and seek additional discounts. To compete these items would result in unacceptable delays, and potential mission failure. In the future, additional discounts will be sought through competition for these products as part of the transition to the MSPV-NG formulary. 9. Market Research: The market research conducted for the MSPV-NG requirement showed there are multiple suppliers capable of providing medical products however; performance is required by October 2016, and VA does not have adequate resources for timely completion of the required items. VA has a need to have consistent, uninterrupted sources of supply that meets system-wide requirements without compromising direct patient care to VA medical centers and/or related facilities. VA has a plan to compete these items and market research supports this acquisition strategy. 10. Any Other Facts Supporting the Justification: SAC is currently establishing competitive single-award BPAs that are beginning to populate the MSPV-NG formulary. Competition is on-going; however, at the onset of MSPV-NG’s period of performance, the formulary will not have sufficient breadth of medical products to meet the operational needs of VA. It is anticipated the MSPV-NG distributors will begin accepting and delivering orders on approximately October 20, 2016, for all items covered in this LSJ. 11. Actions to Increase Competition: As described above, VA will compete future requirements and continuously add necessary products to the MSPV-NG formulary. SAC will work with VHA’s program office to remove or overcome barriers to competition in future acquisitions. VA has and will continue to meet with industry on a periodic basis for continued input and feedback on acquisition strategies. All future acquisitions of MSPV-NG BPAs will be solicited and awarded in a manner that promotes competition to greatest extent practicable. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download